Chromosomal Phasing Non-Invasive Prenatal Testing Market Advances with Cloud-Based Genomic Analytics
The global chromosomal phasing non-invasive prenatal testing (NIPT) market is experiencing a profound paradigm shift. As clinical genetics transitions from basic aneuploidy screening toward comprehensive inherited risk assessment, chromosomal phasing technologies are emerging as essential tools in modern obstetrics. According to market research from Fact.MR, the market is projected to...
0 Comments 0 Shares 53 Views 0 Reviews